Russell Investments Group, Ltd. Rubius Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.79 - $5.98 $9,298 - $70,384	-11,770 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$8.02 - $32.01 $337,289 - $1.35 Million	-42,056 Reduced 78.13%	11,770 $311,000
Q4 2020 Feb 08, 2021	SELL	$4.23 - $8.73 $112,839 - $232,881	-26,676 Reduced 33.14%	53,826 $407,000
Q3 2020 Nov 09, 2020	BUY	$4.65 - $6.25 $138,858 - $186,637	29,862 Added 58.97%	80,502 $402,000
Q2 2020 Aug 05, 2020	SELL	$4.01 - $6.88 $388,548 - $666,637	-96,895 Reduced 65.68%	50,640 $302,000
Q1 2020 May 06, 2020	BUY	$3.74 - $9.84 $551,780 - $1.45 Million	147,535 New	147,535 $656,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.